FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105829250> ?p ?o ?g. }

• W2105829250 endingPage "1925" @default.
• W2105829250 startingPage "1918" @default.
• W2105829250 abstract "Background: Human prostate cancers are initially androgen dependent but ultimately become androgen independent. Overexpression of the Her-2-neu receptor tyrosine kinase has been associated with the progression to androgen independence in prostate cancer cells. We examined the expression of Her-2-neu in normal and cancerous prostate tissues to assess its role in the progression to androgen independence. Methods: Prostate cancer tissue sections were obtained from 67 patients treated by surgery alone (UNT tumors), 34 patients treated with total androgen ablation therapy before surgery (TAA tumors), and 18 patients in whom total androgen ablation therapy failed and who developed bone metastases (androgen-independent [AI] disease). The sections were immunostained for Her-2-neu, androgen receptor (AR), prostate-specific antigen (PSA), and Ki-67 (a marker of cell proliferation) protein expression. Messenger RNA (mRNA) levels and gene amplification of Her-2-neu were examined by RNA in situ hybridization and fluorescent in situ hybridization(FISH), respectively, in a subset of 27 tumors (nine UNT, 11 TAA, and seven AI). All statistical tests were two-sided. Results: Her-2-neu protein expression was statistically significantly higher in TAA tumors than in UNT tumors with the use of two different scoring methods (P = .008 and P = .002). The proportion of Her-2-neu-positive tumors increased from the UNT group (17 of 67) to the TAA group (20 of 34) to the AI group (14 of 18) (P<.001). When compared with UNT tumors, tumor cell proliferation was higher in AI tumors (P = .014) and lower in TAA tumors (P<.001). All tumors expressed AR and PSA proteins. Although Her-2-neu mRNA expression was high in TAA and AI tumors, no Her-2-neu gene amplification was detected by FISH in any of the tumor types. Conclusions: Her-2-neu expression appears to increase with progression to androgen independence. Thus, therapeutic targeting of this tyrosine kinase in prostate cancer may be warranted." @default.
• W2105829250 created "2016-06-24" @default.
• W2105829250 creator A5006660870 @default.
• W2105829250 creator A5007626753 @default.
• W2105829250 creator A5034908463 @default.
• W2105829250 creator A5043769628 @default.
• W2105829250 creator A5045746656 @default.
• W2105829250 creator A5046795494 @default.
• W2105829250 creator A5055056275 @default.
• W2105829250 creator A5055220817 @default.
• W2105829250 creator A5056766924 @default.
• W2105829250 creator A5071763026 @default.
• W2105829250 creator A5082159954 @default.
• W2105829250 creator A5082430991 @default.
• W2105829250 creator A5087350413 @default.
• W2105829250 date "2000-12-06" @default.
• W2105829250 modified "2023-10-16" @default.
• W2105829250 title "Her-2-neu Expression and Progression Toward Androgen Independence in Human Prostate Cancer" @default.
• W2105829250 cites W140697957 @default.
• W2105829250 cites W145447128 @default.
• W2105829250 cites W1529553588 @default.
• W2105829250 cites W1541544453 @default.
• W2105829250 cites W1546746014 @default.
• W2105829250 cites W1580523172 @default.
• W2105829250 cites W1869362176 @default.
• W2105829250 cites W1948931726 @default.
• W2105829250 cites W1974329776 @default.
• W2105829250 cites W1976381106 @default.
• W2105829250 cites W1978018057 @default.
• W2105829250 cites W1988679331 @default.
• W2105829250 cites W2001184843 @default.
• W2105829250 cites W2008498145 @default.
• W2105829250 cites W2009402948 @default.
• W2105829250 cites W2014538286 @default.
• W2105829250 cites W2014938226 @default.
• W2105829250 cites W2025464344 @default.
• W2105829250 cites W2030049072 @default.
• W2105829250 cites W2030819637 @default.
• W2105829250 cites W2032593619 @default.
• W2105829250 cites W2035882803 @default.
• W2105829250 cites W2043236550 @default.
• W2105829250 cites W2046640268 @default.
• W2105829250 cites W2050241533 @default.
• W2105829250 cites W2053535373 @default.
• W2105829250 cites W2058894435 @default.
• W2105829250 cites W2063144184 @default.
• W2105829250 cites W2064157149 @default.
• W2105829250 cites W2065174899 @default.
• W2105829250 cites W2072068836 @default.
• W2105829250 cites W2080645865 @default.
• W2105829250 cites W2082102453 @default.
• W2105829250 cites W2089579900 @default.
• W2105829250 cites W2090653702 @default.
• W2105829250 cites W2094627540 @default.
• W2105829250 cites W2095156669 @default.
• W2105829250 cites W2095705375 @default.
• W2105829250 cites W2104528117 @default.
• W2105829250 cites W2109490785 @default.
• W2105829250 cites W2129750923 @default.
• W2105829250 cites W2129925175 @default.
• W2105829250 cites W2130404651 @default.
• W2105829250 cites W2138684882 @default.
• W2105829250 cites W2141393790 @default.
• W2105829250 cites W2142614941 @default.
• W2105829250 cites W2151453176 @default.
• W2105829250 cites W2151605875 @default.
• W2105829250 cites W2153030011 @default.
• W2105829250 cites W2159448513 @default.
• W2105829250 cites W2232558221 @default.
• W2105829250 cites W2248001437 @default.
• W2105829250 cites W2255182190 @default.
• W2105829250 cites W2408808040 @default.
• W2105829250 cites W2409821120 @default.
• W2105829250 cites W2417322313 @default.
• W2105829250 cites W299669910 @default.
• W2105829250 cites W45711525 @default.
• W2105829250 cites W51158438 @default.
• W2105829250 cites W1857789879 @default.
• W2105829250 doi "https://doi.org/10.1093/jnci/92.23.1918" @default.
• W2105829250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11106683" @default.
• W2105829250 hasPublicationYear "2000" @default.
• W2105829250 type Work @default.
• W2105829250 sameAs 2105829250 @default.
• W2105829250 citedByCount "346" @default.
• W2105829250 countsByYear W21058292502012 @default.
• W2105829250 countsByYear W21058292502013 @default.
• W2105829250 countsByYear W21058292502014 @default.
• W2105829250 countsByYear W21058292502015 @default.
• W2105829250 countsByYear W21058292502016 @default.
• W2105829250 countsByYear W21058292502017 @default.
• W2105829250 countsByYear W21058292502018 @default.
• W2105829250 countsByYear W21058292502019 @default.
• W2105829250 countsByYear W21058292502020 @default.
• W2105829250 countsByYear W21058292502021 @default.
• W2105829250 countsByYear W21058292502022 @default.
• W2105829250 countsByYear W21058292502023 @default.
• W2105829250 crossrefType "journal-article" @default.
• W2105829250 hasAuthorship W2105829250A5006660870 @default.

• next